CPMV (Mosaic ImmunoEngineering) Cyclically Adjusted FCF per Share: $-0.85 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Mosaic ImmunoEngineering Cyclically Adjusted FCF per Share?

Mosaic ImmunoEngineering CPMV +11.11% Cyclically Adjusted FCF per Share is $-0.85 as of Mar. 2026. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Mosaic ImmunoEngineering's adjusted free cash flow per share for the three months ended in Mar. 2026 was $-0.001. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-0.85 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 15.60% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 15.20% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 20.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Mosaic ImmunoEngineering was 30.80% per year. The lowest was -5.10% per year. And the median was 17.00% per year.

As of today (2026-08-01), Mosaic ImmunoEngineering's current stock price is $0.06. Mosaic ImmunoEngineering's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was $-0.85. Mosaic ImmunoEngineering's Cyclically Adjusted Price-to-FCF of today is .


Mosaic ImmunoEngineering  (OTCPK:CPMV) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Mosaic ImmunoEngineering Cyclically Adjusted FCF per Share Related Terms


Mosaic ImmunoEngineering Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Mosaic ImmunoEngineering's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mosaic ImmunoEngineering Cyclically Adjusted FCF per Share Chart

Mosaic ImmunoEngineering Annual Data
Trend May16 May17 May18 May19 May20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.59 -1.48 -1.30 -1.10 -0.89

Mosaic ImmunoEngineering Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.08 -1.03 -0.95 -0.89 -0.85

CPMV vs TCRT, JAGX, BGMS: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Mosaic ImmunoEngineering's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mosaic ImmunoEngineering Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mosaic ImmunoEngineering's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Mosaic ImmunoEngineering's Cyclically Adjusted Price-to-FCF falls into.



Mosaic ImmunoEngineering Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Mosaic ImmunoEngineering's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.001/330.2130*330.2130
=-0.001

Current CPI (Mar. 2026) = 330.2130.

Mosaic ImmunoEngineering Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201605 -0.452 240.229 -0.621
201608 -0.526 240.849 -0.721
201611 -0.342 241.353 -0.468
201702 -0.290 243.603 -0.393
201705 -0.484 244.733 -0.653
201708 -0.287 245.519 -0.386
201711 -0.320 246.669 -0.428
201802 -0.233 248.991 -0.309
201805 -0.262 251.588 -0.344
201808 -0.326 252.146 -0.427
201811 -0.206 252.038 -0.270
201902 -0.134 252.776 -0.175
201905 -0.287 256.092 -0.370
201908 -0.402 256.558 -0.517
201911 -0.346 257.208 -0.444
202002 -0.269 258.678 -0.343
202005 -0.222 256.394 -0.286
202008 -0.579 259.918 -0.736
202011 -0.173 260.229 -0.220
202103 -0.033 264.877 -0.041
202106 -0.021 271.696 -0.026
202109 -0.026 274.310 -0.031
202112 -0.023 278.802 -0.027
202203 -0.026 287.504 -0.030
202206 -0.024 296.311 -0.027
202209 -0.023 296.808 -0.026
202212 -0.023 296.797 -0.026
202303 -0.024 301.836 -0.026
202306 -0.014 305.109 -0.015
202309 -0.015 307.789 -0.016
202312 -0.013 306.746 -0.014
202403 -0.013 312.332 -0.014
202406 -0.016 314.175 -0.017
202409 -0.002 315.301 -0.002
202412 -0.003 315.605 -0.003
202503 -0.004 319.799 -0.004
202506 -0.004 322.561 -0.004
202509 -0.003 324.800 -0.003
202512 -0.004 324.054 -0.004
202603 -0.001 330.213 -0.001

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-0.85 mean?
Mosaic ImmunoEngineering (CPMV) has a Cyclically Adjusted FCF per Share of $-0.85 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Mosaic ImmunoEngineering and its competitors.
Is Mosaic ImmunoEngineering's Cyclically Adjusted FCF per Share too high?
Mosaic ImmunoEngineering's current Cyclically Adjusted FCF per Share is $-0.85.
How does Mosaic ImmunoEngineering's Cyclically Adjusted FCF per Share compare to TCRT and JAGX?
Mosaic ImmunoEngineering's Cyclically Adjusted FCF per Share of $-0.85 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Mosaic ImmunoEngineering and its competitors. Mosaic ImmunoEngineering's current Cyclically Adjusted FCF per Share is $-0.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mosaic ImmunoEngineering stock overvalued right now?
Mosaic ImmunoEngineering (CPMV) has a current Cyclically Adjusted FCF per Share of $-0.85. The current Cyclically Adjusted FCF per Share is $-0.85. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Mosaic ImmunoEngineering (CPMV), the current Cyclically Adjusted FCF per Share is $-0.85 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mosaic ImmunoEngineering Business Description

Address 9114 Adams Avenue, Suite 202, Huntington Beach, CA, USA, 92646
Mosaic ImmunoEngineering Inc is a development-stage biotechnology company focused on bridging immunology and engineering to develop novel immunotherapies to treat and prevent cancer and infectious diseases. It has a single operating segment for the purposes of assessing performance and making operating decisions. The company is pursuing new product candidates and platforms to build a product pipeline based on its deep understanding of immunotherapies.